Close
Open Nav
Participating Companies

Below is a representative list of participating companies for the 2019 CEO & Investor Conference:

AbMax Biotechnology Co.
Acme
Actinium Pharmaceuticals
Aethlon Medical
AiVita Biomedical
American Gene Technologies International 
Anavex Life Sciences 
Anima Biotech 
Arcturus Therapeutics
aTyr Pharma
Avid Bioservices
Axsome Therapeutics
Brainstorm Cell Therapeutics
Caladrius Biosciences
Cantor Fitzgerald & Company
Carmell Therapeutics
CASI Pharmaceuticals
Cell Care Therapeutics
CEL-SCI Corporation
Clinical Network Services (CNS)
co.don AG
Cowen and Company
Cyclacel Pharmaceuticals
Cytodyn 
Delaware Innovation Space
Dyadic International
Editas Medicine
E-Scape Bio
Femtobiomed
Florida Hospital
FreeMind Group
Gila Therapeutics
Greek Trade Office at the Consulate General of Gre
Greenwich LifeSciences
I-APCELL
Immunic Therapeutics
ImmunoMet Therapeutics
Immunomic Therapeutics
Impact Therapeutics
IMV
Infinity Pharmaceuticals
InMed Pharmaceuticals

Interpace Diagnostics Group
Itire Ikate Local Council Development Area (LCDA)
JP Morgan Securities
Landos Biopharma
Leading BioSciences
M/S Kaniz Enterprises
MeiraGTx
MetrioPharm AG
New Orleans Business Alliance
Newron Pharmaceuticals, SpA
NicOx, SA
OncoCyte
Oncolytics Biotech
OncoSec Medical Incorporated
Oyster Point Pharmaceuticals
Paras Biopharmaceuticals Finland Oy
Pipeline Therapeutics
Piper Jaffray & Co.
Precision NanoSystems
Probiodrug AG
Propanc Biopharma
ReForm Biologics
Reneo Pharmaceuticals
Samyang Biopharmaceuticals
Sanofi
Second Genome
Sellas Life Sciences Group
Seraxis
Serina Therapeutics
Servier
ShareVault
Tarveda Therapeutics
test
TONIX Pharmaceuticals
Torreya
Viking Therapeutics
VWR International
Vyriad
Wells Fargo
XCompany
Zynerba Pharmaceuticals

 
*as of 12/10/2018